基层医疗中的华法林抗凝治疗：当前实践及临床医生观点的区域调查
Warfarin anticoagulation in primary care: a regional survey of present practice and clinicians' views.
作者信息
Rodgers H, Sudlow M, Dobson R, Kenny R A, Thomson R G
机构信息
Department of Medicine, University of Newcastle upon Tyne.
出版信息
Br J Gen Pract. 1997 May;47(418):309-10.
Abstract
The demand for anticoagulation services is rising. Warfarin anticoagulation has been shown to reduce the risk of stroke in patients with non-valvular atrial fibrillation by 68%. This raises issues about how services are best organized to initiate and monitor anticoagulation in this potentially large group of patients. We report the results of a regional postal survey undertaken to describe the views of general practitioners and consultants regarding warfarin anticoagulation in light of this potentially high increase in demand.
摘要
对抗凝服务的需求正在上升。华法林抗凝已被证明可将非瓣膜性心房颤动患者的中风风险降低68%。这引发了关于如何以最佳方式组织服务，以便在这一潜在的庞大患者群体中启动和监测抗凝治疗的问题。鉴于需求可能大幅增加，我们报告了一项区域性邮寄调查的结果，该调查旨在描述全科医生和顾问对华法林抗凝的看法。
相似文献
1
Warfarin anticoagulation in primary care: a regional survey of present practice and clinicians' views.基层医疗中的华法林抗凝治疗：当前实践及临床医生观点的区域调查
Br J Gen Pract. 1997 May;47(418):309-10.
2
Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention.医生对心房颤动抗栓治疗应用的看法：确定预防中风的障碍
Intern Med J. 2002 Jan-Feb;32(1-2):15-23.
3
Anticoagulation in atrial fibrillation. Is there a gap in care for ambulatory patients?心房颤动的抗凝治疗。门诊患者的护理是否存在差距？
Can Fam Physician. 2004 Sep;50:1244-50.
4
[Anticoagulation treatment in real-life practice of patient with nonvalvular atrial fibrillation in Beijing city].[北京市非瓣膜性心房颤动患者现实生活中的抗凝治疗]
Zhonghua Yi Xue Za Zhi. 2007 Sep 4;87(33):2328-31.
5
Stroke prevention in atrial fibrillation: are we following the guidelines?心房颤动的卒中预防：我们遵循指南了吗？
N C Med J. 2005 Jan-Feb;66(1):9-13.
6
Which patients with atrial fibrillation do not need anticoagulation therapy with warfarin?哪些心房颤动患者不需要华法林抗凝治疗？
Am Fam Physician. 2004 Sep 1;70(5):917-8.
7
Community-based study of atrial fibrillation and stroke prevention.
Ir Med J. 2004 Jan;97(1):10-2.
8
Occurrence and quality of anticoagulant treatment of chronic atrial fibrillation in primary health care in Sweden: a retrospective study on electronic patient records.瑞典初级卫生保健中慢性房颤抗凝治疗的发生率及质量：一项基于电子病历的回顾性研究
BMC Clin Pharmacol. 2004 Feb 9;4:1. doi: 10.1186/1472-6904-4-1.
9
Patterns of anticoagulation in patients hospitalized with atrial fibrillation: warfarin is underused in paroxysmal atrial fibrillation.
Conn Med. 2003 Nov-Dec;67(10):595-8.
10
Re: 'Avoidance hierarchies and preferences for anticoagulation--semi-qualitative analysis of older patients' views about stroke prevention and the use of warfarin'.主题：“抗凝治疗的回避等级与偏好——老年患者对中风预防及华法林使用观点的半定性分析”
Age Ageing. 2005 Jul;34(4):416; author reply 416-7. doi: 10.1093/ageing/afi095.
引用本文的文献
1
Exploring stakeholder perceptions of implementing a pharmacist-led anticoagulation clinic in primary care settings: a cross-sectional study.探索利益相关者对在基层医疗环境中设立由药剂师主导的抗凝门诊的看法：一项横断面研究。
J Pharm Policy Pract. 2024 Sep 6;17(1):2395529. doi: 10.1080/20523211.2024.2395529. eCollection 2024.
2
Physician decision making in anticoagulating atrial fibrillation: a prospective survey of a physician notification system for atrial fibrillation detected on cardiac implantable electronic devices of patients at increased risk of stroke.心房颤动抗凝治疗中的医生决策：一项针对在心脏植入式电子设备上检测到心房颤动的卒中高危患者的医生通知系统的前瞻性调查。
Ther Adv Cardiovasc Dis. 2018 Apr;12(4):113-122. doi: 10.1177/1753944717749739.
3
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy.意大利非瓣膜性心房颤动患者口服抗凝药使用不足的情况。
Intern Emerg Med. 2007 Mar;2(1):24-8. doi: 10.1007/s11739-007-0005-2. Epub 2007 Mar 31.
4
Anticoagulants for atrial fibrillation: why is the treatment rate so low?用于心房颤动的抗凝剂：为何治疗率如此之低？
Clin Cardiol. 2002 Oct;25(10):447-54. doi: 10.1002/clc.4960251003.
5
Development and description of a decision analysis based decision support tool for stroke prevention in atrial fibrillation.基于决策分析的心房颤动卒中预防决策支持工具的开发与描述
Qual Saf Health Care. 2002 Mar;11(1):25-31. doi: 10.1136/qhc.11.1.25.
6
Randomised trial of two approaches to screening for atrial fibrillation in UK general practice.英国全科医疗中两种心房颤动筛查方法的随机试验。
Br J Gen Pract. 2002 May;52(478):373-4, 377-80.
7
Importance of risk communication and decision making in cardiovascular conditions in older patients: a discussion paper.老年患者心血管疾病中风险沟通与决策的重要性：一篇讨论文章。
Qual Health Care. 2001 Sep;10 Suppl 1(Suppl 1):i19-22. doi: 10.1136/qhc.0100019...
8
Targeting patients with atrial fibrillation and improving their anticoagulation management.针对心房颤动患者并改善他们的抗凝管理。
Clin Cardiol. 2001 May;24(5):355-7. doi: 10.1002/clc.4960240502.
9
Policy dilemmas for oral anticoagulation management.口服抗凝治疗管理中的政策困境
Br J Gen Pract. 2000 Oct;50(459):779-80.
10
Anticoagulation for patients with atrial fibrillation. Editorial may have overinterpreted data.心房颤动患者的抗凝治疗。社论可能过度解读了数据。
BMJ. 2000 Sep 9;321(7261):638-9. doi: 10.1136/bmj.321.7261.638.
本文引用的文献
1
Introduction of computer assisted control of oral anticoagulation in general practice.全科医疗中口服抗凝治疗计算机辅助控制的介绍
J Clin Pathol. 1995 Dec;48(12):1144-6. doi: 10.1136/jcp.48.12.1144.
2
ABC of atrial fibrillation. Atrial fibrillation in general and hospital practice.心房颤动基础。一般及医院环境中的心房颤动。
BMJ. 1996 Jan 20;312(7024):175-8. doi: 10.1136/bmj.312.7024.175.
3
Comparison of anticoagulant control among patients attending general practice and a hospital anticoagulant clinic.普通诊所患者与医院抗凝门诊患者抗凝控制情况的比较。
Br J Gen Pract. 1993 Apr;43(369):152-4.
4
Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice.华法林在非风湿性心房颤动中的应用：来自全科医疗的评论
Br J Gen Pract. 1995 Mar;45(392):153-8.
5
Service provision and use of anticoagulants in atrial fibrillation.心房颤动中抗凝剂的服务提供与使用
BMJ. 1995 Aug 26;311(7004):558-60. doi: 10.1136/bmj.311.7004.558.
Zotero 插件